Healthcare news, data and analysis
Via Investors in Healthcare
UK: Heligan’s Ramesh Jassal talks 2025 trends in healthcare M&A
Heligan Group, a financial institution blending financial guidance with insights and innovations, has released its latest healthcare M&A analysis, reflecting on sector transactions and trends during the first half of […]
Heligan Group, a financial institution blending financial guidance with insights and innovations, has released its latest healthcare M&A analysis, reflecting on sector transactions and trends during the first half of […]
UK: Heligan’s Ramesh Jassal talks 2025 trends in healthcare M&A
August 20, 2025
Analysis
Healthcare
M&A
Heligan Group
Ramesh Jassal
UK: Hartford Care acquires five operational homes in Kent from The Graham Care Group
Hartford Care has added 513 bedrooms to its growing portfolio following the acquisition of five fully operational homes across Kent from The Graham Care Group. The deal brings the total […]
Hartford Care has added 513 bedrooms to its growing portfolio following the acquisition of five fully operational homes across Kent from The Graham Care Group. The deal brings the total […]
UK: Hartford Care acquires five operational homes in Kent from The Graham Care Group
August 20, 2025
Care Homes
M&A
M&A Deals
News
Real Estate
UK: Arishta secures £10m from Growth Lending to fuel vision of a digitally transformed care home sector
Arishta, a new care company led by executive chairman Kalpesh Shah, has secured a £10m investment to fuel a buy-and-build strategy focusing on AI-driven transformation to improve care quality nationwide. Funding is […]
Arishta, a new care company led by executive chairman Kalpesh Shah, has secured a £10m investment to fuel a buy-and-build strategy focusing on AI-driven transformation to improve care quality nationwide. Funding is […]
UK: Arishta secures £10m from Growth Lending to fuel vision of a digitally transformed care home sector
August 19, 2025
Care Homes
M&A
M&A Deals
News
Real Estate
Denmark: Witcher to join Novo Holdings as principal following exit from Ardian
Benjamin Witcher is starting a new position as principal at Novo Holdings, a Denmark-based holding and investment company responsible for managing the assets and the wealth of the Novo Nordisk […]
Benjamin Witcher is starting a new position as principal at Novo Holdings, a Denmark-based holding and investment company responsible for managing the assets and the wealth of the Novo Nordisk […]
Denmark: Witcher to join Novo Holdings as principal following exit from Ardian
August 19, 2025
News
People
Ardian
Benjamin Witcher
Denmark
UK: OXB raises £60m from placement of new shares
LSE-listed Oxford Biomedica (OXB), a cell and gene therapy CDMO, has placed 12,212,857 of new shares at £4.31 per share. Concurrent with existing shareholder taking 1,708,257 new shares, the company […]
LSE-listed Oxford Biomedica (OXB), a cell and gene therapy CDMO, has placed 12,212,857 of new shares at £4.31 per share. Concurrent with existing shareholder taking 1,708,257 new shares, the company […]
UK: OXB raises £60m from placement of new shares
August 19, 2025
News
Pharma
Public Equity
Services – CRO/CMO/CDMO
Briarwood Chase Management
Sweden: Anocca raises SEK440m to advance clinical trial targeting pancreatic cancer
Anocca, a Sweden-based clinical-stage T-cell immunotherapy company, has successfully raised SEK440m (US$46m) in financing led by Mellby Gård with strong support from AMF, Ramsbury and existing shareholders, alongside new investors. […]
Anocca, a Sweden-based clinical-stage T-cell immunotherapy company, has successfully raised SEK440m (US$46m) in financing led by Mellby Gård with strong support from AMF, Ramsbury and existing shareholders, alongside new investors. […]
Sweden: Anocca raises SEK440m to advance clinical trial targeting pancreatic cancer
August 19, 2025
Manufacturing – Specialty Pharma
News
Pharma
Venture
AMF
Germany: Houlihan Lokey provides debt advice on Apelos flexible growth financing
Apelos Therapie, a provider of outpatient physiotherapy, ergotherapy, logopaedics, osteopathy, and sports therapy services in Germany, has obtained financing to support the acquisition of more than 50 practices, significantly scaling […]
Apelos Therapie, a provider of outpatient physiotherapy, ergotherapy, logopaedics, osteopathy, and sports therapy services in Germany, has obtained financing to support the acquisition of more than 50 practices, significantly scaling […]
Germany: Houlihan Lokey provides debt advice on Apelos flexible growth financing
August 18, 2025
Consumer Healthcare
Debt
Healthcare
M&A
News
Europe: StatLab strengthens footprint and scalability in France and Germany
StatLab Medical Products, a US-based global developer and manufacturer of medical diagnostic supplies and equipment, has completed acquisitions of Germany-based histology service and distribution company Histoserve as well as Diapath […]
StatLab Medical Products, a US-based global developer and manufacturer of medical diagnostic supplies and equipment, has completed acquisitions of Germany-based histology service and distribution company Histoserve as well as Diapath […]
Europe: StatLab strengthens footprint and scalability in France and Germany
August 15, 2025
Diagnostics
Healthcare
Life Sciences
M&A
Medtech – Diagnostics
France: Archimed acquires generative AI diagnostics player Arkstone to support fight against infectious disease
France-headquartered healthcare specialist investor Archimed has acquired a majority stake in US-based Arkstone Medical Solutions (Arkstone), a pioneer in infectious disease clinical guidance and antimicrobial stewardship based on machine learning […]
France-headquartered healthcare specialist investor Archimed has acquired a majority stake in US-based Arkstone Medical Solutions (Arkstone), a pioneer in infectious disease clinical guidance and antimicrobial stewardship based on machine learning […]
France: Archimed acquires generative AI diagnostics player Arkstone to support fight against infectious disease
August 15, 2025
Buy Out
Diagnostics
Digital Health/Healthtech
Healthcare
M&A
UK: Kelso Pharma appoints new CFO
Allan Watson, Kelso Pharma’s CFO, has decided to retire from his role and is being succeeded by life sciences financial specialist, Alan King. Watson is one of the founding directors […]
Allan Watson, Kelso Pharma’s CFO, has decided to retire from his role and is being succeeded by life sciences financial specialist, Alan King. Watson is one of the founding directors […]
UK: Kelso Pharma appoints new CFO
August 14, 2025
Manufacturing – Specialty Pharma
News
People
Pharma
Alan King
Turkey: Acibadem strengthens in Turkey with majority acquisition of Bayındır Healthcare Group
Acıbadem Healthcare Group has strengthened its position as Turkey’s leading healthcare provider with the acquisition of 80% of Bayındır Healthcare Group, a subsidiary of Türkiye İş Bank and one of […]
Acıbadem Healthcare Group has strengthened its position as Turkey’s leading healthcare provider with the acquisition of 80% of Bayındır Healthcare Group, a subsidiary of Türkiye İş Bank and one of […]
Turkey: Acibadem strengthens in Turkey with majority acquisition of Bayındır Healthcare Group
August 14, 2025
Dental
Healthcare
Hospitals and Clinics
M&A
News
Northern Ireland: BGF makes multi-million-pound investment in CWC Group
BGF, a non-controlling equity investor to growing businesses in the UK and Ireland, has made a multi-million-pound investment in CWC Group, a family-owned specialist care provider, based in Northern Ireland. Founded […]
BGF, a non-controlling equity investor to growing businesses in the UK and Ireland, has made a multi-million-pound investment in CWC Group, a family-owned specialist care provider, based in Northern Ireland. Founded […]
Northern Ireland: BGF makes multi-million-pound investment in CWC Group
August 13, 2025
Care Homes
News
Social Care
Venture
Aisling Byrne
UK: Panthera Biopartners accelerating expansion with backing from LDC
Panthera Biopartners, the UK’s largest Site Management Organisation (SMO) for commercial clinical trials, has secured investment from LDC, a private equity investor and part of Lloyds Banking Group, to support […]
Panthera Biopartners, the UK’s largest Site Management Organisation (SMO) for commercial clinical trials, has secured investment from LDC, a private equity investor and part of Lloyds Banking Group, to support […]
UK: Panthera Biopartners accelerating expansion with backing from LDC
August 13, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Spain: Esteve CDMO gains physical foothold in US with Regis Technologies
Global family-owned pharma company, Esteve, has acquired US-based API CDMO Regis Technologies, a move that provides Esteve CDMO (actively operating under the Esteve Química brand) with a physical presence in the […]
Global family-owned pharma company, Esteve, has acquired US-based API CDMO Regis Technologies, a move that provides Esteve CDMO (actively operating under the Esteve Química brand) with a physical presence in the […]
Spain: Esteve CDMO gains physical foothold in US with Regis Technologies
August 12, 2025
M&A
News
Pharma
Services – CRO/CMO/CDMO
Andrea Oro
Spain: StepStone and Greykite to acquire majority stake in Vitalia Home from CVC and Portobello
Reports point to the conclusion of the rumoured sale of Vitalia Home, a Spain-based care home group. US-listed real estate investment manager StepStone and UK-based Greykite, an independent European real […]
Reports point to the conclusion of the rumoured sale of Vitalia Home, a Spain-based care home group. US-listed real estate investment manager StepStone and UK-based Greykite, an independent European real […]
Spain: StepStone and Greykite to acquire majority stake in Vitalia Home from CVC and Portobello
August 12, 2025
Buy Out
Care Homes
M&A
M&A Deals
News
New Zealand: T-Pro strengthens presence in New Zealand and Australia with Sound Business Systems
Ireland-based provider of AI-powered speech technology and clinical documentation solutions to the healthcare sector, T-Pro, a portfolio company of mid-market PE investor Livingbridge, has acquired New Zealand-based Sound Business Systems […]
Ireland-based provider of AI-powered speech technology and clinical documentation solutions to the healthcare sector, T-Pro, a portfolio company of mid-market PE investor Livingbridge, has acquired New Zealand-based Sound Business Systems […]
New Zealand: T-Pro strengthens presence in New Zealand and Australia with Sound Business Systems
August 12, 2025
Buy Out
Digital Health/Healthtech
Healthcare
M&A
News
Australia: System C Healthcare acquires MYP Technologies to drive international growth in health and social care
System C, a UK-based technology company supporting over 700,000 users across 400 customers, in the NHS, private healthcare and social care across the UK and other geographies, has acquired Australian […]
System C, a UK-based technology company supporting over 700,000 users across 400 customers, in the NHS, private healthcare and social care across the UK and other geographies, has acquired Australian […]
Australia: System C Healthcare acquires MYP Technologies to drive international growth in health and social care
August 12, 2025
Buy Out
Digital Health/Healthtech
Healthcare
M&A
News
Netherlands: Astorg-backed Normec makes entry into US TICC market
Normec, a Netherlands-headquartered European provider of Testing, Inspection, Certification, and Compliance (TICC) services, has made its entry into the US – the largest TICC market worldwide – through the acquisition […]
Normec, a Netherlands-headquartered European provider of Testing, Inspection, Certification, and Compliance (TICC) services, has made its entry into the US – the largest TICC market worldwide – through the acquisition […]
Netherlands: Astorg-backed Normec makes entry into US TICC market
August 11, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
The Netherlands: AVS Bio expands antibody discovery and protein production capabilities with acquisition of IPE European carve-out
US-based Arlington Capital Partners’ portfolio company AVS Bio, a global provider of critical inputs and services for the bioprocessing and biologics industries, has acquired ImmunoPrecise Antibodies (Europe), a carve-out of Nasdaq-listed ImmunoPrecise […]
US-based Arlington Capital Partners’ portfolio company AVS Bio, a global provider of critical inputs and services for the bioprocessing and biologics industries, has acquired ImmunoPrecise Antibodies (Europe), a carve-out of Nasdaq-listed ImmunoPrecise […]
The Netherlands: AVS Bio expands antibody discovery and protein production capabilities with acquisition of IPE European carve-out
August 11, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Italy: Azzurra and TCD acquiring DMX Pharma from Alto Partners and Trilantic
Luxembourg-headquartered international private equity fund, Azzurra Capital, and The Club Dealers (TCD), an initiative promoted by Carlo Mammola and Enrico Ricotta, two prominent figures in the Italian private equity landscape, […]
Luxembourg-headquartered international private equity fund, Azzurra Capital, and The Club Dealers (TCD), an initiative promoted by Carlo Mammola and Enrico Ricotta, two prominent figures in the Italian private equity landscape, […]
Italy: Azzurra and TCD acquiring DMX Pharma from Alto Partners and Trilantic
August 8, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
US: Riverside Company closes Value Fund II at hard cap of US$750m
The Riverside Company, a global investment firm focused on lower middle market investments, has held the final close of Riverside Value Fund II (RVF II) at its hard cap of […]
The Riverside Company, a global investment firm focused on lower middle market investments, has held the final close of Riverside Value Fund II (RVF II) at its hard cap of […]
US: Riverside Company closes Value Fund II at hard cap of US$750m
August 7, 2025
News
The Riverside Company
US
Switzerland: Alcon to acquire STAAR Surgical for US$1.5bn
Switzerland-headquartered Alcon (SIX/NYSE), the largest eye care device company in the world, has agreed to acquire Nasdaq-listed STAAR Surgical, the designer, developer and manufacturer of implantable lenses for the eye. […]
Switzerland-headquartered Alcon (SIX/NYSE), the largest eye care device company in the world, has agreed to acquire Nasdaq-listed STAAR Surgical, the designer, developer and manufacturer of implantable lenses for the eye. […]
Switzerland: Alcon to acquire STAAR Surgical for US$1.5bn
August 6, 2025
Healthcare
M&A
News
Ophthalmology
Alcon
Pragmatism, partnership, and purpose: Diaverum’s approach to embedding sustainability into strategy and operations
In June, Diaverum released its 2024 ESG report. For the Swedish-born, multinational provider of life-enhancing renal care to patients with chronic kidney disease, ESG is woven through its strategy and […]
In June, Diaverum released its 2024 ESG report. For the Swedish-born, multinational provider of life-enhancing renal care to patients with chronic kidney disease, ESG is woven through its strategy and […]
Pragmatism, partnership, and purpose: Diaverum’s approach to embedding sustainability into strategy and operations
August 6, 2025
Analysis
Clinical Labs
Healthcare
Hospitals and Clinics
News
UK: Avery Healthcare strengthens position in UK premium care sector with acquisition of Artisan Care
Avery Healthcare a UK national care home provider, has completed the acquisition of Artisan Care Group, the owner of 10 newly developed care homes, comprising 774 high-quality care beds. The […]
Avery Healthcare a UK national care home provider, has completed the acquisition of Artisan Care Group, the owner of 10 newly developed care homes, comprising 774 high-quality care beds. The […]
UK: Avery Healthcare strengthens position in UK premium care sector with acquisition of Artisan Care
August 5, 2025
Care Homes
M&A
News
Social Care
Artisan Care Group
Singapore: Efor completes third acquisition of the year with integration of PES
France-based Efor, Group, a life sciences consultancy, has acquired Process Engineering Specialists (PES), a Singapore based consultancy providing project management, construction management, and commissioning & qualification services across the biotechnology, […]
France-based Efor, Group, a life sciences consultancy, has acquired Process Engineering Specialists (PES), a Singapore based consultancy providing project management, construction management, and commissioning & qualification services across the biotechnology, […]
Singapore: Efor completes third acquisition of the year with integration of PES
August 4, 2025
M&A
News
Pharma
Services – Medical Communications
Efor Group
Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
The latest insights from
Compass Carter Osborne
Attracting US investors: what UK life science companies need to know
Attracting US investors: what UK life science companies need to know
June 10, 2025
Insight
Life Science
